Adeno-associated viral vector gene therapy for canine hemophilia
Rare Disease and Orphan Drugs Journal · 03.03.2026 · 5 (1)
DOI: 10.20517/rdodj.2025.66 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rare Disease and Orphan Drugs Journal, online erschienen am 03.03.2026. Verfasst von Bhavya S. Doshi und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 144 Literaturangaben.
Abstract (Originalsprache)
Hemophilia A (HA) and B (HB) are monogenic X-linked disorders caused by plasma coagulant factor VIII (FVIII) and IX (FIX) deficiency, respectively, and occur naturally in a variety of dog breeds. While several animal models of hemophilia exist, the canine model closely mimics the genotypic, phenotypic, and immunologic characteristics of the disorder in humans. Consequently, decades of research were conducted in the canine model of hemophilia, ultimately leading to licensed liver-directed adeno-associated viral (AAV) vector-mediated gene therapy for HA and HB in humans. The studies from both research colony and companion hemophilic dogs with AAV liver-directed gene therapy support the safety and efficacy of this platform in canines. Here, we provide practical considerations with respect to the administration and monitoring of liver-directed AAV gene therapy for hemophilia in veterinary clinical practice and review the data on efficacy and safety of AAV gene therapy in canine hemophilia.
Zitieren
APA
Doshi, B. S., Crudele, J. M., & Callan, M. B. (2026). Adeno-associated viral vector gene therapy for canine hemophilia. Rare Disease and Orphan Drugs Journal, 5(1). https://doi.org/10.20517/rdodj.2025.66
Vancouver
Doshi BS, Crudele JM, Callan MB. Adeno-associated viral vector gene therapy for canine hemophilia. Rare Disease and Orphan Drugs Journal. 2026;5(1). doi:10.20517/rdodj.2025.66
BibTeX
@article{Doshi2026,
author = {Doshi, Bhavya S. and Crudele, Julie M. and Callan, Mary Beth},
title = {Adeno-associated viral vector gene therapy for canine hemophilia},
journal = {Rare Disease and Orphan Drugs Journal},
year = {2026},
volume = {5},
number = {1},
doi = {10.20517/rdodj.2025.66}
}
EUVIMED